Reply To: Avacta

#6053
Nick Hargrave
Keymaster

https://www.londonstockexchange.com/news-article/AVCT/update-on-ava6000-phase-1a-clinical-trial-progress/16387750

More positive news on the clinical data. It remains a mystery why positive news was not released before such a poorly executed raise. Still seeking answers but hopefully the share price can return to a reasonable valuation now the funding concern has been dealt with